OneMedNet shares surge 14.78% premarket as AI-ready platform validation and network expansion drive optimism.

OneMedNet (ONMD) surged 14.78% in premarket trading following the announcement of its AI-ready Real-World Data platform validation and a 380-provider site network expansion, which strengthened its position in healthcare data analytics. The company also reported an 815% year-over-year increase in Q3 bookings, driven by strategic partnerships, including a collaboration with Palantir, and a SaaS subscription model rollout. These developments, coupled with a 13 million rise in de-identified patient records and 50 million additional clinical exams, signaled operational momentum despite ongoing financial challenges. The news reinforced investor confidence in ONMD’s long-term growth potential, aligning with the stock’s upward trajectory ahead of its regular trading session.